Forensic Services Available Nationally

Clinical Psychiatry Services

Clinical Psychiatry Services

Forensic Services Available Nationally

Meet Dr. Crowley

Dr. Crowley, a Yale Medical School alumnus and graduate of the Washington Psychoanalytic Institute, has been practicing psychiatry— clinical, forensic, and administrative— for over fifty years. He now conducts all sessions by telemedicine.

In his forensic practice, which is both extensive and varied, he has served as psychiatric consultant, examiner, and expert witness in many types of civil and criminal cases, in the courts of several states (AL, CA, DC, DE, FL, GA, KY, LA, MD, MI, MO, NC, NJ, NV, NY, OH, PA, SC, TX, VA, WI, WV, WY) as well as in federal courts and courts martial. He has worked on matters of all kinds where state of mind is at issue. His recent cases have involved issues of: security clearance; fitness for duty; malpractice; capacity to contract; testamentary capacity and undue influence; PTSD; trauma and stress; sexual misconduct by professionals; sexual harassment; stalking; hospital standards; dangerousness assessments in the workplace; criminal responsibility; competence for trial; presentencing recommendations to Court; eligibility for release from incarceration.

Overview of Practice

Dr. Crowley teaches at the Uniformed Services University of the Health Sciences in Bethesda, where he is Adjunct Professor of Psychiatry. He was honored by receiving the Roeske Award for Excellence in Medical Student Education from the American Psychiatric Association. He is actively involved in the USUHS clinical research team which leads in the study of PTSD and other stress disorders. Dr. Crowley is a member of the Center For the Study of Traumatic Stress.

Psych News Alert

FDA Issues Warning About Dental Risk With Transmucosal Buprenorphine

The U.S. Food and Drug Administration (FDA) has issued a Drug Safety Communication about dental problems associated with the use of buprenorphine products that dissolve in the mouth (transmucosal) and is requiring that a new warning about the risk of dental problems be added to the prescribing information and patient medication guides for these products.… [...]

Absence of Mood Improvement in Two Weeks May Predict Failure to Respond to TMS

If patients with major depressive disorder (MDD) demonstrate only limited mood improvements after two weeks of repetitive transcranial magnetic stimulation (rTMS), it may be a sign their treatment plans should be adjusted, suggests a study published in Depression & Anxiety. “Insurers typically approve 36 [rTMS] sessions for patients with MDD. ... It is imperative to… [...]

FDA Approves Novel Drug to Treat Insomnia

The U.S. Food and Drug Administration (FDA) has approved Quviviq (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia. The FDA has recommended that Quviviq be classified as a controlled substance, and it is expected to be available to patients in May 2022, following scheduling by the U.S Drug Enforcement… [...]

Are you ready to take the next step?

For forensic inquiries, please call Dr. Crowley at 202-537-3300 or email him.

For patient appointments, call or text Alyssa Cotter at 240-831-1892 or email her.

Don’t Hesitate To
Contact Us

Have a question? Get in touch now!

group 38
Call Us:
Email Us:

Don’t Hesitate To
Contact Us

Have a question? Get in touch now!

group 38
Call Us:
group 68
Email Us:

Book An Appointment

  • * All indicated fields must be completed.
  • This field is for validation purposes and should be left unchanged.
Scroll to Top